Literature DB >> 24888600

Autologous human cytomegalovirus-specific cytotoxic T cells as rescue therapy for ulcerative enteritis in primary immunodeficiency.

Rachele Ciccocioppo1, Patrizia Comoli, Alessandra Gallia, Sabrina Basso, Fausto Baldanti, Gino Roberto Corazza.   

Abstract

PURPOSE: Patients affected by primary immunodeficiency usually undergo a wide range of infections, including reactivation of latent ones. Here we report two cases suffering from late-onset combined immunodeficiency in which ulcerative enteritis due to human Cytomegalovirus caused a life-threatening malabsorption syndrome.
METHODS: The assessment of the viral load was carried out on both blood and mucosal samples by quantitative real-time polymerase chain reaction assay. The generation of autologous virus-specific cytotoxic T cell lines was performed according to Good Manufacturing Practice protocol after peripheral blood mononuclear cells were collected through a single leukapheresis.
RESULTS: In both patients, the viral load resulted negligible in peripheral blood, but very high in mucosal specimens (range 1.064 - 1.031.692 copies/10(5) cells). After two rounds of antiviral therapy proved unsuccessful, the generation of virus-specific cytotoxic T cell lines was carried out despite severe lymphopenia, and their infusion resulted safe and durably effective in healing intestinal ulcerations and resetting the viral load.
CONCLUSIONS: Virus-specific cellular therapy was useful in reconstituting specific immunity and treating severe human Cytomegalovirus-related enteritis in patients with primary immunodeficiency.

Entities:  

Mesh:

Year:  2014        PMID: 24888600     DOI: 10.1007/s10875-014-0060-1

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  19 in total

1.  Defining combined immunodeficiency.

Authors:  Chaim M Roifman; Raz Somech; Fotini Kavadas; Linda Pires; Amit Nahum; Ilan Dalal; Eyal Grunebaum
Journal:  J Allergy Clin Immunol       Date:  2012-06-02       Impact factor: 10.793

2.  The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease.

Authors:  Georgia Malamut; Virginie Verkarre; Felipe Suarez; Jean-François Viallard; Anne-Sophie Lascaux; Jacques Cosnes; Yoram Bouhnik; Olivier Lambotte; Dominique Béchade; Marianne Ziol; Anne Lavergne; Olivier Hermine; Nadine Cerf-Bensussan; Christophe Cellier
Journal:  Am J Gastroenterol       Date:  2010-06-15       Impact factor: 10.864

3.  Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication.

Authors:  Patrizia Comoli; Massimo Labirio; Sabrina Basso; Fausto Baldanti; Paolo Grossi; Milena Furione; Mario Viganò; Roberto Fiocchi; Giorgio Rossi; Fabrizio Ginevri; Bruno Gridelli; Antonia Moretta; Daniela Montagna; Franco Locatelli; Giuseppe Gerna; Rita Maccario
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

Review 4.  Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome.

Authors:  R S Wildin; S Smyk-Pearson; A H Filipovich
Journal:  J Med Genet       Date:  2002-08       Impact factor: 6.318

5.  CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.

Authors:  M Farrington; L S Grosmaire; S Nonoyama; S H Fischer; D Hollenbaugh; J A Ledbetter; R J Noelle; A Aruffo; H D Ochs
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

Review 6.  CMV-specific T cell therapy.

Authors:  Hermann Einsele; Markus Kapp; Götz Ulrich Grigoleit
Journal:  Blood Cells Mol Dis       Date:  2007-09-11       Impact factor: 3.039

7.  Cytomegalovirus enteritis in common variable immunodeficiency.

Authors:  Elizabeth Stack; Kay Washington; George R Avant; Glenn M Eisen
Journal:  South Med J       Date:  2004-01       Impact factor: 0.954

8.  Cytomegalovirus-specific T cell immunotherapy promotes restoration of durable functional antiviral immunity following allogeneic stem cell transplantation.

Authors:  Karl S Peggs; Stephanie Verfuerth; Arnold Pizzey; Shoon-Ling C Chow; Kirsty Thomson; Stephen Mackinnon
Journal:  Clin Infect Dis       Date:  2009-12-15       Impact factor: 9.079

Review 9.  Unravelling the association of partial T-cell immunodeficiency and immune dysregulation.

Authors:  Adrian Liston; Anselm Enders; Owen M Siggs
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

10.  IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID.

Authors:  Dominic Paquin-Proulx; Bianca A N Santos; Karina I Carvalho; Myrthes Toledo-Barros; Ana Karolina Barreto de Oliveira; Cristina M Kokron; Jorge Kalil; Markus Moll; Esper G Kallas; Johan K Sandberg
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

View more
  4 in total

Review 1.  Is It Feasible to Use CMV-Specific T-Cell Adoptive Transfer as Treatment Against Infection in SOT Recipients?

Authors:  Estéfani García-Ríos; Marcos Nuévalos; Francisco J Mancebo; Pilar Pérez-Romero
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

Review 2.  Persistent Immune Activation in CVID and the Role of IVIg in Its Suppression.

Authors:  Dominic Paquin-Proulx; Johan K Sandberg
Journal:  Front Immunol       Date:  2014-12-16       Impact factor: 7.561

3.  Case Report: Cytomegalovirus Disease Is an Under-Recognized Contributor to Morbidity and Mortality in Common Variable Immunodeficiency.

Authors:  Samantha Chan; Jack Godsell; Miles Horton; Anthony Farchione; Lauren J Howson; Mai Margetts; Celina Jin; Josh Chatelier; Michelle Yong; Joseph Sasadeusz; Jo A Douglass; Charlotte A Slade; Vanessa L Bryant
Journal:  Front Immunol       Date:  2022-02-15       Impact factor: 7.561

4.  Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28-29 2017, Doha, Qatar).

Authors:  Sara Deola; Bella S Guerrouahen; Heba Sidahmed; Anjud Al-Mohannadi; Muhammad Elnaggar; Ramaz Elsadig; Essam M Abdelalim; Goran Petrovski; Massimo Gadina; Adrian Thrasher; Winfried S Wels; Stephen P Hunger; Ena Wang; Francesco M Marincola; Cristina Maccalli; Chiara Cugno
Journal:  J Transl Med       Date:  2018-10-10       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.